Search
for
Sort by
Research 331–360 of 513
- Alopecia areata
- Risks and side effects in the medical management of benign prostatic hyperplasia
- Persistent Sexual Dysfunction with Finasteride 1 mg Taken for Hair Loss
- Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Apremilast is efficacious in refractory alopecia areata
- The ‘bald’ phenotype (androgenetic alopecia) is caused by the high glycaemic, high cholesterol and low mineral ‘western diet’
- Non-FDA-Approved Uses of Apremilast in Dermatology: A Review of Current Available literature
- Wider clinical applications of fumaric acid esters: A useful option in psoriasis patients with multiple sclerosis
- Approaching Erectile Dysfunction in Dermatology Patients
- The urologic impact of long-term finasteride 1-mg use for androgenic alopecia: a matched-cohort database analysis
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Medical management of benign prostatic hyperplasia
- Platelet-Rich Plasma for Urologic Conditions: An Early Call for Composition Reporting
- 1113 Targeting anti-inflammatory immunonanocarriers to human and murine neutrophils via Ly6 antigen for psoriasiform dermatitis alleviation
- PD49-03 IS TADALAFIL ASSOCIATED WITH DECREASED RISK OF MAJOR ADVERSE CARDIAC EVENTS OR VENOUS THROMBOEMBOLISM IN MEN WITH LOWER URINARY TRACT SYMPTOMS?
- 22-Year-Old Male with Several Discrete Patches of Hair Loss
- Treatment of actinic cheilitis with ingenol mebutate gel: Experience in four patients
- Study of QuantiFERON’S conversion/reversal phenomena in patients with psoriasis during biological treatment
- FDA approves label addition for PDE-5 inhibitor
- Caffeine and Its Role in Regulation the Androgenetic Alopecia.
- 8 Finasteride-Associated Suicide and Depression in Men Treated for Hypogonadism and Impotence
- Evaluation of risk of SSRI-associated impotence and low libido in men exposed to finasteride
- Anti‐hair loss effect of a shampoo containing caffeine and adenosine
- A COMPREHENSIVE REVIEW ON PHARMACOLOGICAL POTENTIALS OF CAFFEINE
- Apremilast for extensive and treatment-resistant alopecia areata: a retrospective analysis of five patients
- PD49-02 MEDICATIONS MOST COMMONLY ASSOCIATED WITH ERECTILE DYSFUNCTION: EVALUATION OF THE FOOD AND DRUG ADMINISTRATION NATIONAL PHARMACOVIGILANCE DATABASE
- Lower Urinary Tract Symptoms: What’s New in Medical Treatment?
- Lower Urinary Tract Symptoms in Men